Post-Exposure Prophylaxis with SA58 (anti-COVID-19 monoclonal antibody) Nasal Spray for the prevention of symptomatic Coronavirus Disease 2019 in healthy adult workers: A randomized, single-blind, placebo-controlled clinical study
Rui Song, Gang Zeng, Jianxing Yu, Xing Meng, Xiaoyou Chen, Jing Li, Xiaoliang Xie, Xiaojuan Lian, Zhiyun Zhang, Yunlong Cao, Weidong Yin, Ronghua Jin
doi: https://doi.org/10.1101/2022.12.28.22283666
Rui Song
aBeijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China
Gang Zeng
bSinovac Biotech, Ltd., Beijing 100085, P.R. China
Jianxing Yu
bSinovac Biotech, Ltd., Beijing 100085, P.R. China
Xing Meng
bSinovac Biotech, Ltd., Beijing 100085, P.R. China
Xiaoyou Chen
aBeijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China
Jing Li
cSinovac Life Sciences Ltd., Beijing 102601, P.R. China
Xiaoliang Xie
dBiomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, P.R. China
eChangping Laboratory, Beijing 102206, P.R. China
Xiaojuan Lian
cSinovac Life Sciences Ltd., Beijing 102601, P.R. China
Zhiyun Zhang
aBeijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China
Yunlong Cao
dBiomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, P.R. China
eChangping Laboratory, Beijing 102206, P.R. China
Weidong Yin
bSinovac Biotech, Ltd., Beijing 100085, P.R. China
Ronghua Jin
aBeijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
- Supplementary material[supplements/283666_file04.docx]
Posted January 03, 2023.
Post-Exposure Prophylaxis with SA58 (anti-COVID-19 monoclonal antibody) Nasal Spray for the prevention of symptomatic Coronavirus Disease 2019 in healthy adult workers: A randomized, single-blind, placebo-controlled clinical study
Rui Song, Gang Zeng, Jianxing Yu, Xing Meng, Xiaoyou Chen, Jing Li, Xiaoliang Xie, Xiaojuan Lian, Zhiyun Zhang, Yunlong Cao, Weidong Yin, Ronghua Jin
medRxiv 2022.12.28.22283666; doi: https://doi.org/10.1101/2022.12.28.22283666
Post-Exposure Prophylaxis with SA58 (anti-COVID-19 monoclonal antibody) Nasal Spray for the prevention of symptomatic Coronavirus Disease 2019 in healthy adult workers: A randomized, single-blind, placebo-controlled clinical study
Rui Song, Gang Zeng, Jianxing Yu, Xing Meng, Xiaoyou Chen, Jing Li, Xiaoliang Xie, Xiaojuan Lian, Zhiyun Zhang, Yunlong Cao, Weidong Yin, Ronghua Jin
medRxiv 2022.12.28.22283666; doi: https://doi.org/10.1101/2022.12.28.22283666
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12139)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4035)
- Geriatric Medicine (380)
- Health Economics (671)
- Health Informatics (2607)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3804)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6473)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (52)
- Transplantation (185)
- Urology (165)